Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ILMN – Illumina, Inc.

Illumina, Inc.
ILMN
$116.38
Name : Illumina, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $17,887,604,736.00
EPSttm : 5.45
finviz dynamic chart for ILMN
Illumina, Inc.
$116.38
2.46%
$2.94

Float Short %

5.59

Margin Of Safety %

14

Put/Call OI Ratio

0.57

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.7

Price

116.33

Target Price

135.32

Analyst Recom

2.46

Performance Q

-4.39

Relative Volume

1.08

Beta

1.47

Ticker: ILMN




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-13ILMN146.930.400.7053062
2026-01-14ILMN143.920.420.4053456
2026-01-15ILMN145.340.421.0353617
2026-01-16ILMN141.640.420.3153664
2026-01-20ILMN147.170.460.3821407
2026-01-21ILMN152.540.451.1521905
2026-01-22ILMN153.990.451.1022111
2026-01-23ILMN150.360.450.2222315
2026-01-26ILMN153.40.460.2922354
2026-01-27ILMN152.120.460.8322592
2026-01-28ILMN149.920.460.2722573
2026-01-29ILMN149.660.460.2122575
2026-01-30ILMN144.760.461.1622660
2026-02-02ILMN141.110.470.5922938
2026-02-03ILMN135.340.460.8622810
2026-02-05ILMN133.550.491.0023652
2026-02-09ILMN117.240.500.3326220
2026-02-10ILMN119.310.560.6525210
2026-02-11ILMN116.380.570.0325708
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-13ILMN147.0041.160.54.71
2026-01-14ILMN143.9241.130.04.71
2026-01-15ILMN145.3241.159.94.71
2026-01-16ILMN141.6443.125.74.71
2026-01-20ILMN147.1343.188.94.71
2026-01-21ILMN152.5143.186.64.71
2026-01-22ILMN153.9843.160.44.71
2026-01-23ILMN150.1943.126.44.71
2026-01-26ILMN153.0044.068.64.71
2026-01-27ILMN152.1744.045.34.71
2026-01-28ILMN150.0445.037.34.71
2026-01-29ILMN149.6445.049.24.71
2026-01-30ILMN144.7445.017.94.71
2026-02-02ILMN141.1445.025.64.71
2026-02-03ILMN135.3445.010.24.71
2026-02-04ILMN134.0245.040.44.71
2026-02-05ILMN133.5145.045.74.71
2026-02-06ILMN119.6745.0-52.04.71
2026-02-09ILMN117.2516.930.05.07
2026-02-10ILMN119.329.168.35.14
2026-02-11ILMN116.339.125.65.14
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-13ILMN-0.011.324.58
2026-01-14ILMN-0.011.324.58
2026-01-15ILMN-0.011.324.58
2026-01-16ILMN-0.011.324.58
2026-01-20ILMN-0.011.654.58
2026-01-21ILMN-0.011.654.58
2026-01-22ILMN-0.011.654.58
2026-01-23ILMN-0.011.654.58
2026-01-26ILMN-0.012.034.58
2026-01-27ILMN-0.012.034.58
2026-01-28ILMN-0.012.034.35
2026-01-29ILMN-0.012.034.35
2026-01-30ILMN-0.012.034.35
2026-02-02ILMN-0.011.734.35
2026-02-03ILMN-0.011.734.35
2026-02-04ILMN-0.011.734.35
2026-02-05ILMN-0.011.734.35
2026-02-06ILMN-0.011.734.35
2026-02-09ILMN-0.011.494.35
2026-02-10ILMN-0.011.494.35
2026-02-11ILMN-0.001.495.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

1.06

Avg. EPS Est. Next Quarter

1.24

Insider Transactions

Institutional Transactions

1.49

Beta

1.47

Average Sales Estimate Current Quarter

1073

Average Sales Estimate Next Quarter

1105

Fair Value

132.15

Quality Score

92

Growth Score

41

Sentiment Score

46

Actual DrawDown %

78.5

Max Drawdown 5-Year %

-86.2

Target Price

135.32

P/E

21.34

Forward P/E

19.99

PEG

1.82

P/S

4.1

P/B

7.48

P/Free Cash Flow

17.78

EPS

5.45

Average EPS Est. Cur. Y​

5.14

EPS Next Y. (Est.)

5.84

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

19.59

Relative Volume

1.08

Return on Equity vs Sector %

1.7

Return on Equity vs Industry %

18.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

25.6
Illumina, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees:
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading